FDA 483 OBSERVATION · #794 OF 1,932 MOST-CITED
Backflow prevention - general
FDA cited this observation 25 times across 24 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
How FDA worded it — real examples
Lack of backflow prevention in the installation of pipes conveying potable water to fixtures and equipment.
Lack of backflow prevention in the installation of pipes conveying potable water to fixtures and equipment.
Lack of backflow prevention in the installation of pipes conveying potable water to equipment.
Lack of backflow prevention in the installation of fittings conveying potable water to equipment.
Lack of backflow prevention in the installation of pipes conveying potable water to equipment.
Lack of backflow prevention in the installation of pipes and fittings conveying potable water to equipment.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →